Product information

From Health Canada

Current status:

Cancelled Post Market

Current status date:

2015-10-26

Original market date: See footnote 1

1994-12-31

Product name:

RATIO-CLONAZEPAM

DIN:

02103737 Electronic product monograph is not available

Company:

RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED
30 Novopharm Court
Toronto
Ontario
Canada M1B 2K9

Class:

Human

Dosage form(s):

Tablet

Route(s) of administration:

Oral

Number of active ingredient(s):

1

Schedule(s):

Targeted (CDSA IV)

 

American Hospital Formulary Service (AHFS): See footnote 3

28:12.08 

Anatomical Therapeutic Chemical (ATC): See footnote 4

N03AE01 CLONAZEPAM

Active ingredient group (AIG) number:See footnote5

0111558002

List of active ingredient(s)
Active ingredient(s) See footnote8 Strength
CLONAZEPAM 2 MG
Version 4.0.3

"Page details"

Date modified: